Tada said

“Almost 100% of Alzheimer's trials have failed. Here's a company crowing about an upcoming conference they are presenting at about an Alzheimer's leg of a trial. To me this is very exciting news. What are they setting the stage for?“

well Hopefully not setting the stage for a failed primary outcome of their BOM trial. 

Sorry, I am usually more “a glass half full” kind of guy. But this topic (in relation to my comment) has been discussed here before. To get the exciment and or ball rolling on the potential other positive effects of 208 in the event of a failed primary outcome. When I saw the news release, I couldn’t help but think alternative thought. I remain hopeful. 

Regards

DND